Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00348400 · ClinicalTrials.gov registry record · Phase 4
Brimonidine Purite 0.15% Versus Dorzolamide 2% Used as Adjunctive Therapy to Latanoprost
A Phase 4 study, sponsored by Innovative Medical.
- Completed
- Registry status
- Phase 4
- Development phase
NCT00348400: Completed Phase 4 study, sponsored by Innovative Medical.
NCT00348400 is a Phase 4 study that has completed, run by Innovative Medical. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00348400, a Phase 4 study, has completed, sponsored by Innovative Medical.
- COMPLETED
- Registry status
- Phase 4
- Development phase
Study Summary
Evaluate the relative efficacy and tolerability of Alphagan P compared to Trusopt as adjunctive therapy
Interventions
- DRUG Brimonidine Purite 0.15%, Dorzolamide 2%, Latanoprost
Trial Details
| Field | Value |
|---|---|
| Phase | Phase 4 |
What the finished NCT00348400 record still lists
NCT00348400 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Brimonidine Purite 0.15%, Dorzolamide 2%, Latanoprost is the first listed.
NCT00348400 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00348400 about?
NCT00348400 is a clinical study titled "Brimonidine Purite 0.15% Versus Dorzolamide 2% Used as Adjunctive Therapy to Latanoprost". Evaluate the relative efficacy and tolerability of Alphagan P compared to Trusopt as adjunctive therapy
What is the current status of trial NCT00348400?
This trial is currently completed. It is a Phase 4 study.
What interventions are being tested in trial NCT00348400?
The interventions under investigation include: Brimonidine Purite 0.15%, Dorzolamide 2%, Latanoprost (DRUG).
Who is sponsoring clinical trial NCT00348400?
This trial is sponsored by Innovative Medical, which has 44 total clinical trials registered on ClinicalTrials.gov.